Drug Trial Radar · NCT07587788
RBD5044 in Chinese Participants With Hypertriglyceridemia
Last checked: Nov 19, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Feb 28, 2026
Primary completion
Mar 2027
Study completion Mar 2027
Sponsor
- Lead sponsor
- Ribotek Biopharmaceuticals (Shandong) Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- May 14, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if drug RBD5044 works to treat hypertriglyceridemia in adults. It will also learn about the safety of drug RBD5044. The main questions it aims to answer are: Does drug RBD5044 reduce the triglyceride levels? What medical problems may participants experience when taking drug RBD5044? Researchers will compare drug RBD5044 to a placebo to see if drug RBD5044 works to treat hypertriglyceridemia. Participants will: Receive RBD5044 or placebo twice during the trial (Day 1 and Day 84).
Conditions
- Hypertriglyceridemia
Interventions
RBD5044Drug
Active drug
PlaceboDrug
Placebo that is identical in appearance and volume to the dose of active IMP
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in fasting serum triglyceride (TG) levels at week 16Time frame: From baseline to week 16
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Peking University First Hospital
Beijing, China
Daqing People's Hospital
Daqing, Heilongjiang, China
The Fourth Hospital of Harbin Medical University
Harbin, Heilongjiang, China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Jingzhou Central Hospital
Jingzhou, Hubei, China
The First Affiliated Hospital of Nanyang Medical College
Nanyang, Nanyang, China
Yuncheng Central Hospital
Yuncheng, Shanxi, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.